4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-008902
President & CEO sold 5,466 shares at an average $23.49 ($128,373)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Warmuth Markus President & CEO | 2026-01-07 | Sale 10b5-1 | −3,707 | $23.24 | $86,159 | 620,696 | D |
| Warmuth Markus President & CEO | 2026-01-07 | Sale 10b5-1 | −1,450 | $23.88 | $34,620 | 619,246 | D |
| Warmuth Markus President & CEO | 2026-01-07 | Sale 10b5-1 | −309 | $24.57 | $7,593 | 618,937 | D |
| Open-market sales · 5,466 sh · avg $23.49 · $128,373 | |||||||
Loading xslF345X05/ownership.xml…